Voximetry and Medpace Core Laboratories, a full-service core laboratory, have entered a strategic partnership aimed at enhancing radiopharmaceutical clinical trials through the integration of cutting-edge dosimetry technology and comprehensive contract…

Voximetry and Y-mAbs, a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radiopharmaceuticals and commercial-stage antibody-based therapeutic products for the treatment of cancer, have entered into a…

Voximetry has received a Medical Device Single Audit Program (MDSAP) Certificate, bringing the company one step closer to market clearance for clinical use of its Torch Dose Assessment software in…

Voximetry received a $2 million grant from the U.S. Cancer Institute, part of the National Institutes of Health, to enhance the efficiency and accuracy of conventional nuclear medicine SPECT/CT imaging,…

Voximetry has partnered with Flywheel, a medical imaging AI platform powering healthcare innovation through streamlined data management, curation and analysis, the company announced recently. According to a release, the collaboration…

Voximetry received 510(k) market clearance from the U.S. Food and Drug Administration for its Torch Dose Assessment for Radiopharmaceutical Therapy, the company announced recently. According to a release, Torch can…

Voximetry won the Greater Madison Chamber of Commerce’s annual Pressure Chamber pitch contest held Tuesday at the Majestic Theater and earned an all-expenses-paid trip to meet investment firms in Silicon…